Keryx Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KERX and buy or sell other stocks, ETFs, and their options commission-free!About KERX
Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.
CEOJodie P. Morrison
CEOJodie P. Morrison
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1998
Founded1998
Employees—
Employees—
KERX Key Statistics
Market cap404.49M
Market cap404.49M
Price-Earnings ratio-4.41
Price-Earnings ratio-4.41
Dividend yield—
Dividend yield—
Average volume2.10M
Average volume2.10M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.98
52 Week high$5.98
52 Week low$2.47
52 Week low$2.47
Stock Snapshot
As of today, Keryx Biopharmaceuticals(KERX) shares are valued at $3.36. The company's market cap stands at 404.49M, with a P/E ratio of -4.41.
Keryx Biopharmaceuticals(KERX) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
Keryx Biopharmaceuticals(KERX) shares are trading with a volume of 0, against a daily average of 2.1M.
During the past year, Keryx Biopharmaceuticals(KERX) stock moved between $2.47 at its lowest and $5.98 at its peak.
During the past year, Keryx Biopharmaceuticals(KERX) stock moved between $2.47 at its lowest and $5.98 at its peak.